Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150.
Saved in:
| Title: | Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150. |
|---|---|
| Authors: | Sho, Takuya1 (AUTHOR), Suda, Goki1 (AUTHOR) gsudgast@pop.med.hokudai.ac.jp, Yamamoto, Yoshiya2 (AUTHOR), Furuya, Ken3 (AUTHOR), Baba, Masaru3 (AUTHOR), Ogawa, Koji1 (AUTHOR), Kubo, Akinori1 (AUTHOR), Tokuchi, Yoshimasa1 (AUTHOR), Fu, Qingjie1 (AUTHOR), Yang, Zijian1 (AUTHOR), Kimura, Megumi1 (AUTHOR), Kitagataya, Takashi1 (AUTHOR), Maehara, Osamu4 (AUTHOR), Ohnishi, Shunsuke4 (AUTHOR), Nakamura, Akihisa1 (AUTHOR), Yamada, Ren1 (AUTHOR), Ohara, Masatsugu1 (AUTHOR), Kawagishi, Naoki1 (AUTHOR), Natsuizaka, Mitsuteru1 (AUTHOR), Nakai, Masato1 (AUTHOR) |
| Source: | Cancers. Aug2022, Vol. 14 Issue 16, p3938. 18p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
